These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30187924)

  • 1. Topical 5-fluorouracil in dermatologic disease.
    Prince GT; Cameron MC; Fathi R; Alkousakis T
    Int J Dermatol; 2018 Oct; 57(10):1259-1264. PubMed ID: 30187924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review.
    Prince GT; Cameron MC; Fathi R; Alkousakis T
    J Drugs Dermatol; 2018 Mar; 17(3):274-280. PubMed ID: 29537445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
    Moore AY
    J Dermatolog Treat; 2009; 20(6):328-35. PubMed ID: 19954388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
    Yoon J; Phibbs CS; Chow A; Weinstock MA;
    J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders.
    Ceilley RI
    J Dermatolog Treat; 2012 Apr; 23(2):83-9. PubMed ID: 21034289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
    Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
    Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.
    Askew DA; Mickan SM; Soyer HP; Wilkinson D
    Int J Dermatol; 2009 May; 48(5):453-63. PubMed ID: 19416373
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
    Ingham AI; Weightman W
    Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?
    Epstein E
    J Am Acad Dermatol; 1998 Jan; 38(1):77-80. PubMed ID: 9448209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse therapy with 5-FU in eradicating actinic keratoses with less than recommended dosage.
    Robins P
    J Drugs Dermatol; 2002 Jul; 1(1):25-30. PubMed ID: 12847751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label uses of topical vitamin D in dermatology: a systematic review.
    Wat H; Dytoc M
    J Cutan Med Surg; 2014; 18(2):91-108. PubMed ID: 24636434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
    Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
    J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
    Pei S; Kaminska ECN; Tsoukas MM
    Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil-induced exacerbation of rosacea.
    Haddock ES; Cohen PR
    Dermatol Online J; 2016 Nov; 22(11):. PubMed ID: 28329576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
    Kaur RR; Alikhan A; Maibach HI
    J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study.
    Ondo AL; Padilla RS; Miedler JD; Cockerell CJ; Kerner JD; Steiner RL; Mings SM; Shanler SD
    Dermatol Surg; 2012 Sep; 38(9):1469-76. PubMed ID: 22712515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation.
    Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):30-6. PubMed ID: 12353678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.